At the news
? NEUTRALIMPACT 4/10 CLUSTER filed Mar 3, 2026 at 19:00 ET
GeneDx CEO and CFO conducted open-market share sales totaling $587,754 over four days, while also receiving non-cash stock awards and exercising options. The sales represent a routine level of insider activity relative to the company's $2.3B market cap.
- CEO Katherine Stueland sold 5,861 shares for $454,967 in an open-market transaction.
- CFO Kevin Feeley sold a total of 1,711 shares across two transactions for $132,787.
- Total open-market sales by insiders in the cluster amount to $587,754 over seven days.
- CEO and CFO also received stock awards totaling 62,946 shares with no cash value (non-cash events).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access